melanocyte-stimulating hormone (MSH)
A hormone released from the pituitary in response to light exposure that stimulates skin pigmentation and dopamine release; mimicked by melanotan peptides
As defined in Benefits & Risks of Peptide Therapeutics for Physical & Mental Health
Where it comes up · 2
- Worse Than Asbestos? The CIRS Rabbit Hole | Dr. Scott McMahon & Dr. Ritchie Shoemaker | EP 4154 claims
- Benefits & Risks of Peptide Therapeutics for Physical & Mental Health1 claim
Most important claims · 5 of 5Search all claims for “melanocyte-stimulating hormone (MSH)” →
- The melanocortin system is activated by viewing light or getting ultraviolet-B light on the skin, which stimulates signals from the eyes to the hypothalamus to the pituitary, leading to release of melanocyte-stimulating hormone that causes skin tanning and parallel dopamine release.Benefits & Risks of Peptide Therapeutics for Physical & Mental Health
- CIRS is associated with the obesity epidemic and leptin resistance; leptin binds to gp130 cytokine receptor in hypothalamus to activate POMC (pro-opiomelanocortin) production of MSH; leptin resistance blocks MSH production, causing fatigue, pain, and obesity. The combination of obesity, leptin resistance, and MSH deficiency is particularly severe; molecular hypometabolism compounds the problem. If 40% of Americans become morbidly obese by 2030, and if CIRS affects 25% of the population, there is massive overlap producing a metabolic catastrophe.Worse Than Asbestos? The CIRS Rabbit Hole | Dr. Scott McMahon & Dr. Ritchie Shoemaker | EP 415
- The primary biomarkers used to diagnose CIRS are: (1) Visual Contrast Sensitivity (VCS) test—abnormally low sensitivity indicating retinal microcirculation dysfunction; (2) HLA-DR genetic susceptibility; (3) Melanocyte-stimulating hormone (MSH)—abnormally low; (4) Cytokine levels—abnormally elevated; (5) TGF-beta-1 (transforming growth factor beta 1)—abnormally elevated. These biomarkers are chosen because they are validated to separate cases from healthy controls and show objective improvement with treatment.Worse Than Asbestos? The CIRS Rabbit Hole | Dr. Scott McMahon & Dr. Ritchie Shoemaker | EP 415
- Patients who recover from CIRS (via remediation and treatment) remain genetically susceptible (HLA type does not change); they retain vulnerability to reactivation if reexposed to water-damaged buildings. However, if MSH levels rise to normal during treatment, some individuals may gain functional resistance. Those who travel extensively or cannot guarantee mold-free environments should take prophylactic medications continuously (e.g., low-dose VIP, which has essentially zero side effects).Worse Than Asbestos? The CIRS Rabbit Hole | Dr. Scott McMahon & Dr. Ritchie Shoemaker | EP 415
- Carnivore diet reduces inflammatory load by eliminating plant-derived compounds; in CIRS patients with low MSH, carnivore diet appears effective at improving symptoms; once CIRS treatment achieves maximum medical improvement and VIP restores metabolic function, dietary restrictions can potentially be expanded beyond carnivoreWorse Than Asbestos? The CIRS Rabbit Hole | Dr. Scott McMahon & Dr. Ritchie Shoemaker | EP 415